Sir,
Raj et al. reported on “cerebrospinal fluid cytokines, matrix metalloproteinases, HIV and tuberculous meningitis.[1]” Raj et al. noted that “HIV infection did not affect a majority of the CSF cytokines and MMP levels in tuberculous meningitis (TBM) except for IL-1β level.[1]” In fact, many reports show that HIV infection results in alteration of CSFcytokine[2] and matrix metalloproteinases.[3] Juan et al. reported that “CSF INF-gamma levels (>6.4 IU/mL) are very valuable in TBM diagnosis.[4]” The question is why the observation by Raj et al. is different. First, the confounding medical disorders, including to the opportunistic infection, should be well considered. For example, the Cryptococcal meningitis can affect the CSF cytokine,[5,6] and cytokine therapy is also an alternative treatment for the Cryptococcal meningitis.[7] A further study with control of confounding medical disorder and treatment in HIV-infected cases is suggested.
References
- 1.Rai D, Garg RK, Mahdi AA, Jain A, Verma R, Tripathi AK, et al. Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis. Ann Indian Acad Neurol. 2014;17:171–8. doi: 10.4103/0972-2327.132617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Thea DM, Porat R, Nagimbi K, Baangi M, St Louis ME, Kaplan G, et al. Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med. 1996;124:757–62. doi: 10.7326/0003-4819-124-8-199604150-00009. [DOI] [PubMed] [Google Scholar]
- 3.Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D’Agostino C, Vullo V, et al. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol. 2000;6:156–63. doi: 10.3109/13550280009013159. [DOI] [PubMed] [Google Scholar]
- 4.Juan RS, Sánchez-Suárez C, Rebollo MJ, Folgueira D, Palenque E, Ortuño B, et al. Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis. J Neurol. 2006;253:1323–30. doi: 10.1007/s00415-006-0215-y. [DOI] [PubMed] [Google Scholar]
- 5.Naranbhai V, Chang CC, Durgiah R, Omarjee S, Lim A, Moosa MY, et al. Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection. AIDS. 2014;28:657–66. doi: 10.1097/QAD.0000000000000200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chang CC, Omarjee S, Lim A, Spelman T, Gosnell BI, Carr WH, et al. Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome. J Infect Dis. 2013;208:1604–12. doi: 10.1093/infdis/jit388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Jarvis JN, Meintjes G, Rebe K, Williams GN, Bicanic T, Williams A, et al. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: A randomized controlled trial. AIDS. 2012;26:1105–13. doi: 10.1097/QAD.0b013e3283536a93. [DOI] [PMC free article] [PubMed] [Google Scholar]